Skye Bioscience Balance Sheet (2012-2014) | SKYE

Balance Sheet Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jun2014
Assets
Current Assets
Cash & Equivalents 13,082.0026,404.0023,261.0029,712.0037,151.0052,186.0046,476.0049,952.00528,494.00
Cash & Current Investments 13,082.0026,404.0023,261.0029,712.0037,151.0052,186.0046,476.0049,952.00528,494.00
Receivables - Net 6,906.0032,078.0028,666.0025,338.0034,802.0035,425.00
Receivables 6,906.0032,078.0028,666.0025,338.0034,802.0035,425.00
Prepaid Assets 3,107.003,808.0015,591.0013,978.00
Current Assets 38,348.0064,897.0087,058.00106,134.00103,650.0087,915.00
Non-Current Assets
Property, Plant & Equipment (Net) 69,471.0041,933.0039,560.0037,186.0034,813.00
Non-Current Assets 4,536.0069,471.0041,933.0039,560.0037,186.0034,813.00
Assets 42,884.00134,368.00128,991.00145,694.00140,836.00122,728.00
Liabilities
Current Liabilities
Accounts Payables 4,079.009,534.0011,134.0015,079.0012,791.0013,992.00
Notes Payables 41,149.0052,523.0047,238.0041,048.0035,355.00
Payables 4,079.0050,683.0063,657.0062,317.0053,839.0049,347.00
Accumulated Expenses 4,325.0052,929.0064,245.00
Current Taxes 246.001,384.00588.00
Total Current Liabilities 4,325.0062,317.0053,839.0049,347.00
Non-Current Liabilities
Non-Current Debt 15,851.00
Total Liabilities 4,325.0068,780.0064,245.0062,317.0053,839.0049,347.00
Shareholder's Equity
Total Debt 15,851.00
Common Equity 38,559.0065,588.0064,746.0083,377.0086,997.0073,381.00
Shareholder's Equity 38,559.0065,588.0064,746.0083,377.0086,997.0073,381.00
Liabilities and Shareholders Equity 42,884.00134,368.00128,991.00145,694.00140,836.00122,728.00
Retained Earnings -459.00-2688.00-1846.003,323.00-297.0013,319.00